Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

54 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   11c-acetate   Acetate   -   -   -   [3]
13,
86,
88 
 2   [18f]fluoro-2-deoxy-2-d-glucose   D-glucose   D00009   -   -   [2]
86,
88 
 3   Acetate   Acetate   -   -   -   [40]
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 4   Act-064992   -   -   -   -   [4]
85,
86,
88,
210 
 5   Adempas®   Riociguat   D09572   [3] GUCY1A1, GUCY1A2, GUCY1B1   [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [2]
86,
88 
 6   Ambrisentan   Ambrisentan   D07077   [1] EDNRA   [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [6]
51,
84,
85,
86,
88,
211 
 7   Ambrisentan 5 mg   Ambrisentan   D07077   [1] EDNRA   [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
88 
 8   Ammonia   Ammonia   D02916   -   -   [1]
88 
 9   Atorvastatin   Atorvastatin   D00258, D00887, D07474   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [17]
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 10   Barnascan   -   -   -   -   [1]
88 
 11   Bay 63-2521   -   -   -   -   [2]
86,
88 
 12   Bay 63-2521 ir tablet 1.0 mg   -   -   -   -   [1]
88 
 13   Bay 63-2521 ir tablet 1.5 mg   -   -   -   -   [1]
88 
 14   Bay 63-2521 ir tablet 2.0 mg   -   -   -   -   [1]
88 
 15   Bay 63-2521 ir tablet 2.5 mg   -   -   -   -   [1]
88 
 16   Bay 63-2521 tablets 0.5 mg   -   -   -   -   [2]
86,
88 
 17   Bay 63-2521 tablets 1 mg   -   -   -   -   [2]
86,
88 
 18   Bay 63-2521 tablets 1.5 mg   -   -   -   -   [2]
86,
88 
 19   Bay 63-2521 tablets 2 mg   -   -   -   -   [2]
86,
88 
 20   Bay 63-2521 tablets 2.5 mg   -   -   -   -   [2]
86,
88 
 21   Bay1237592   -   -   -   -   [2]
86,
88 
 22   Bosentan   Bosentan   D01227, D07538   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [9]
13,
41,
47,
51,
84,
85,
86,
88,
210 
 23   Bosentan monohydrate   Bosentan   D01227, D07538   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [4]
51,
84,
86,
88 
 24   Cysteine   L-cysteine   D00026, D02326   -   -   [9]
6,
13,
19,
84,
85,
88,
90,
254,
296 
 25   D-glucose   D-glucose   D00009   -   -   [3]
49,
86,
88 
 26   Date   Date   -   -   -   [3]
6,
88,
113 
 27   Edoxaban   Edoxaban   D09546, D09710   [1] F10   [1] Complement and coagulation cascades   [2]
46,
88 
 28   Fludeoxyglucose   -   -   -   -   [1]
88 
 29   Gsk1325760   -   -   -   -   [2]
86,
88 
 30   Iodine   Iodine   D00108   -   -   [2]
46,
88 
 31   Macitentan   Macitentan   D10135   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [5]
51,
85,
86,
88,
210 
 32   Macitentan 10 mg   Macitentan   D10135   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [2]
86,
88 
 33   Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb   -   -   -   -   [2]
86,
88 
 34   Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth   -   -   -   -   [2]
86,
88 
 35   Multihance   Gadobenic acid   D04283, D08018   -   -   [2]
86,
88 
 36   N-acetyl cysteine   L-cysteine   D00026, D02326   -   -   [5]
13,
19,
85,
88,
296 
 37   Ns-304   -   -   -   -   [3]
70,
86,
88 
 38   Ns-304 placebo   -   -   -   -   [2]
70,
88 
 39   Opsumit   Macitentan   D10135   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [2]
86,
88 
 40   Opsumit®   -   -   -   -   [3]
86,
88,
210 
 41   Oxygen   Oxygen   D00003   -   -   [14]
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 42   Ph-combination therapy   -   -   -   -   [2]
86,
88 
 43   Ph-monotherapy   -   -   -   -   [2]
86,
88 
 44   Placebo   -   -   -   -   [20]
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 45   Riociguat   Riociguat   D09572   [3] GUCY1A1, GUCY1A2, GUCY1B1   [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [6]
51,
84,
86,
88,
225,
299 
 46   Riociguat (adempas, bay63-2521)   Riociguat   D09572   [3] GUCY1A1, GUCY1A2, GUCY1B1   [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [3]
51,
86,
88 
 47   Ro 47-0203   Bosentan   D01227, D07538   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [4]
51,
85,
86,
88 
 48   Selexipag   Selexipag   D09994   [1] PTGIR   [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   [5]
51,
70,
84,
86,
88 
 49   Thrombin   Thrombin   D00090   -   -   [2]
86,
88 
 50   Tracleer   Bosentan   D01227, D07538   [2] EDNRA, EDNRB   [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [8]
13,
51,
84,
85,
86,
88,
210,
211 
 51   Treprostinil   Treprostinil   D06213   [1] PTGIR   [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   [5]
51,
84,
85,
86,
88 
 52   Treprostinil sodium   Treprostinil   D06213   [1] PTGIR   [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   [2]
86,
88 
 53   Volibris   Ambrisentan   D07077   [1] EDNRA   [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [3]
51,
86,
88 
 54   Warfarin   Warfarin   D00564, D01280, D08682   [2] NQO1, VKORC1   [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   [10]
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 

Back to top